The potential advantages of infrared spectroscopic imaging for examination of cells and tissue biopsies for cancer histopathology is high, however there are fundamental limitations of FTIR that must first be addressed. One limitation is that Infrared spectroscopy lacks the sensitivity to detect biomarkers of disease directly. With cancer being one of the leading causes of death and its increasing prevalence, it is important to develop tools that can rapidly screen and enable rapid and simultaneous fingerprinting of biologic content and metabolic state. To address these limitations, probed Infrared spectroscopy is being explored. We report the successful synthesis, characterization, and application of metal carbonyl loaded nanoparticle probes for the detection of breast cancer biomarkers.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.